Implementation and validation of a Bayesian method for accurately forecasting duration of optimal pharmacodynamic target attainment with dalbavancin during long-term use for subacute and chronic staphylococcal infections.
- DOI
- 10.1016/j.ijantimicag.2023.107038
- Published
- 2024 Jan
- Container
- International journal of antimicrobial agents
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.ijantimicag.2023.107038,
title = {Implementation and validation of a Bayesian method for accurately forecasting duration of optimal pharmacodynamic target attainment with dalbavancin during long-term use for subacute and chronic staphylococcal infections.},
author = {Cojutti PG and Gatti M and Punt N and Douša J and Zamparini E and Tedeschi S and Viale P and Pea F},
year = {2024},
journal = {International journal of antimicrobial agents},
doi = {10.1016/j.ijantimicag.2023.107038},
url = {https://doi.org/10.1016/j.ijantimicag.2023.107038}
}RIS
TY - JOUR TI - Implementation and validation of a Bayesian method for accurately forecasting duration of optimal pharmacodynamic target attainment with dalbavancin during long-term use for subacute and chronic staphylococcal infections. AU - Cojutti PG AU - Gatti M AU - Punt N AU - Douša J AU - Zamparini E AU - Tedeschi S AU - Viale P AU - Pea F PY - 2024 JO - International journal of antimicrobial agents DO - 10.1016/j.ijantimicag.2023.107038 UR - https://doi.org/10.1016/j.ijantimicag.2023.107038 ER -
APA
PG, C., M, G., N, P., J, D., E, Z., S, T., P, V., & F, P. (2024). Implementation and validation of a Bayesian method for accurately forecasting duration of optimal pharmacodynamic target attainment with dalbavancin during long-term use for subacute and chronic staphylococcal infections.. International journal of antimicrobial agents. https://doi.org/10.1016/j.ijantimicag.2023.107038
Source records
- pubmed · retrieved 2026-09-26T17:17:33.101Z
- europe-pmc · retrieved 2026-09-26T17:17:33.114Z